The story of Viagra and its effect on the drug landscape presents a intriguing question for potential backers. Initially a blockbuster drug, competitors have significantly diminished its market dominance, creating challenges for companies connected to the original patent holder and subsequent formulas. While some firms might profit from niche Viagr